国家药监局药审中心关于发布《新冠肺炎疫情期间药物临床试验管理指导原则（试行）》的通告
類型: 連結 作者: 国家药品监督管理局药品审评中心 連結: https://mp.weixin.qq.com/s/ZKjsNm3d33m1ockwFsEhKQ
專家點評、公告
Convalescent Plasma for COVID-19: More Questions Than Answers
類型: 連結 作者: Carlos del Rio 出處: NEJM Journal Watch 連結:...
Discharged COVID-19 Patients Without Symptoms Often Have Positive SARS-CoV-2 PCR Tests
類型: 連結 作者: Thomas L. Schwenk 出處: NEJM Journal Watch 連結:...
10 things doctors should know about COVID-19
類型: 連結 作者: Stephen Padilla 出處: MIMS 連結:...
NEJM重磅：美国首项瑞德西韦临床试验初步结果正式发表，作者解释备受争议的临床终点修改问题
類型: 連結 作者: NEJM医学前沿 出處: NEJM医学前沿 連結: https://mp.weixin.qq.com/s/mpeaxUNCNraDQCtKTaMN_A
《柳叶刀》炮轰特朗普！顶尖医学杂志冲天一怒，号召美国人抛弃他
類型: 連結 作者: 兵器 出處: 今日头条 連結:...
Don’t rely on contact-tracing apps
類型: 連結 作者: The Economist 出處: The Economist 連結: https://www.economist.com/leaders/2020/05/16/dont-rely-on-contact-tracing-apps
Does Vitamin D Protect Against COVID-19?
類型: 連結 作者: JoAnn E. Manson 出處: Medscape 連結: https://www.medscape.com/viewarticle/930152
OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.
類型: 連結 作者: The OpenSAFELY Collaborative et al. 出處: Medrxiv 連結: https://www.medrxiv.org/content/10.1101/2020.05.06.20092999v1
Remdesivir: Drug has ‘clear-cut ‘power to fight coronavirus
Remdesivir cut the duration of symptoms from 15 days down to 11 in clinical trial at hospitals around the world.The full details have not been published……